A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It? - KFF Health News
Source: KHN
April Dembosky, KQED A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance policies. The lack of guidance could limit use of the drug, which is both novel — it targets…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at KHN